Skip to main content
. 2022 Aug 27;146(16):1210–1224. doi: 10.1161/CIRCULATIONAHA.122.061754

Table 4.

Adverse Events in Patients Assigned to Dapagliflozin or Placebo According to the Frailty Index

graphic file with name cir-146-1210-g007.jpg